Caspase recruitment domain-containing protein 19 (CARD19)

CARD19 (caspase recruitment domain-containing protein 19) is a mitochondrial protein belonging to the CARD family, a group of adaptor proteins that mediate protein-protein interactions in apoptosis and immune signaling pathways. CARD19 is highly expressed in immune cells such as T-cells, macrophages, and microglia[4][8]. It was originally thought to prevent Bcl10-induced NF-κB activation but recent research shows that while overexpression can reduce Bcl10 protein and inhibit NF-κB in cell lines, endogenous CARD19 in T-cells does not have a major effect on canonical NF-κB signaling[2][4][7]. CARD19 localizes predominantly to mitochondria, with no evidence of significant cytosolic or nuclear distribution under physiological conditions. Its precise physiological function remains only partially characterized, but it has been linked to immune regulation and mitochondrial homeostasis, and may modulate cytokine production in activated macrophages[4][2][7]. There are no direct drug interactions or disease-modifying therapies currently linked to CARD19. Its function and biology may be more relevant to immune modulation and mitochondrial processes than to classical receptor or enzyme mechanics[2][4][7].

Other names

BinCARDC9orf89

Not established for therapeutic modulation; proposed mechanisms from overexpression/knockout experiments include modulation of NF-κB activity and promotion of Bcl10 degradation